CALA — Calithera Biosciences Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
U.S. STOCKS ON THE MOVE-Aurora Cannabis, Teledyne Techologies, Moderna Inc
U.S. STOCKS ON THE MOVE-FLIR Systems, Ryerson Holding, Acorda Therapeutics, Inovio
U.S. STOCKS ON THE MOVE-Genworth Financial, FLIR Systems, Magellan Health
Calithera Biosciences: Slumps after missing main goal of cancer study
U.S. STOCKS ON THE MOVE-Ocugen Inc, Enzo Biochem, Kaixin Auto, oil stocks
Brief: Calithera Biosciences Inc To Reduce Workforce By About 35%
Brief: Calithera Biosciences Presents New Preclinical Data For CB-668 At Society For Immunotherapy Of Cancer 2020 Annual Meeting
Brief: Calithera Biosciences Reports Third Quarter 2020 Financial Results And Recent Highlights
Brief: Calithera Biosciences Announces Expansion Of Co's Ongoing Clinical Trial Evaluating Telaglenastat In Combination With Pfizer's Cdk 4/6 Inhibitor Palbociclib
Brief: Calithera Biosciences Inc - Awarded Up To $2.4 Million From Cystic Fibrosis Foundation To Support Clinical Development Of Arginase Inhibitor, Cb-280
Brief: Calithera Biosciences Initiates Keapsake Randomized Phase 2 Trial Of Telaglenastat In Combination With Chemoimmunotherapy
Development Obligations Under Incyte Agreement
Brief: Calithera Biosciences Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Calithera Biosciences Files For Stock Offering Of Up To $75 Mln
Brief: Calithera Biosciences Inc Files For Mixed Shelf Of Up To $250 Million
Brief: Calithera Biosciences Reports Q2 Loss Per Share $0.29
Brief: Calithera Biosciences Appoints Scott Garland To Board
Brief: Calithera Initiates Phase 1 Trial Of Cb-280 For Cystic Fibrosis
Calithera Biosciences slides on equity raise